Pharmigene, Inc. vs Sofiva Genomics Co., Ltd.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Pharmigene, Inc. is the larger company by market value: $34 M against $19 M for Sofiva Genomics Co., Ltd., 1.8 times as much (market caps of Jan 5, 2024 for Pharmigene, Inc. and Nov 19, 2026 for Sofiva Genomics Co., Ltd.). Pharmigene, Inc.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
Market value, the same start = 100
From Jan 2022: how each one's value moved, whatever its size.
Side by side
| Measure | Pharmigene, Inc. 7595.TWO | Sofiva Genomics Co., Ltd. 6615.TWO · #24,402 in the world |
|---|---|---|
| Profile | ||
| Country | 🇹🇼 Taiwan | 🇹🇼 Taiwan |
| Sector | Healthcare | Healthcare |
| Industry | Diagnostics and Research | Diagnostics and Research |
| Founded | — | — |
| Size | ||
| Market cap | $34 M* | $19 M |
| Altman Z-score zone | — | — |
| Data as of | Market cap Jan 2024 | Market cap Nov 2026 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, Pharmigene, Inc. or Sofiva Genomics Co., Ltd.?
Pharmigene, Inc. is the larger company by market value: $34 M against $19 M for Sofiva Genomics Co., Ltd., 1.8 times as much (market caps of Jan 5, 2024 for Pharmigene, Inc. and Nov 19, 2026 for Sofiva Genomics Co., Ltd.). Pharmigene, Inc.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
More about Pharmigene, Inc.
More about Sofiva Genomics Co., Ltd.
Sources#
Every figure on this page comes from these, with the date shown next to it.